Fredrik Widman - 27 Feb 2026 Form 4 Insider Report for INTUITIVE SURGICAL INC (ISRG)

Signature
By: Stephanie Lim-Ignacio For: Widman, Fredrik
Issuer symbol
ISRG
Transactions as of
27 Feb 2026
Net transactions value
-$299,233
Form type
4
Filing time
03 Mar 2026, 18:17:13 UTC
Previous filing
27 Feb 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Widman Fredrik VP Corporate Controller 1020 KIFER ROAD, SUNNYVALE By: Stephanie Lim-Ignacio For: Widman, Fredrik 03 Mar 2026 0001897970

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ISRG Common Stock Sale $124,428 -249 -22% $499.71 909 27 Feb 2026 Direct F1
transaction ISRG Common Stock Options Exercise $0 +468 +51% $0.000000 1,377 28 Feb 2026 Direct F2
transaction ISRG Common Stock Tax liability $117,318 -233 -17% $503.51 1,144 28 Feb 2026 Direct F2
transaction ISRG Common Stock Sale $57,487 -118 -10% $487.18 1,026 03 Mar 2026 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ISRG Restricted Stock Units Options Exercise $0 -468 -100% $0.000000 0 28 Feb 2026 Common Stock 468 $0.000000 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 21, 2026.
F2 RSUs vest 25% per year over a four year period, commencing on the first anniversary of the grant date. RSUs convert into common stock on the vest date on a one-for-one basis. 25% of the shares have been released and a portion of the shares were held back to cover the statutory tax withholding requirements. The net shares were deposited into the holders account.
F3 Each RSU granted represents a contingent right to receive one share of Intuitive Surgical common stock. The grant vests 25% on the first anniversary of the date of grant and annually thereafter, over a four year period.